ProMIS Neurosciences (PMN) Institutional Ownership $0.52 -0.02 (-2.80%) As of 03:56 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for ProMIS Neurosciences (NASDAQ:PMN)CurrentInstitutional OwnershipPercentage50.13%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$4.51MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$411.72K Get PMN Insider Trade Alerts Want to know when executives and insiders are buying or selling ProMIS Neurosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PMN Institutional Buying and Selling by Quarter ProMIS Neurosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Allostery Investments LP233,703$165K0.2%+19.8%0.715% 5/16/2025 Ally Bridge Group NY LLC1,484,699$1.03M0.9%-6.8%4.542% 5/15/2025 Armistice Capital LLC2,334,826$1.62M0.0%-7.0%7.143% 2/17/2025 Allostery Investments LP195,111$185K0.2%N/A0.597% 2/14/2025 Heights Capital Management Inc.160,207$152K0.1%-58.6%0.490% 11/15/2024 Sphera Funds Management LTD.1,929,297$2.41M0.4%+6.3%6.455% 11/14/2024 Ally Bridge Group NY LLC1,592,605$1.99M1.1%+50.3%5.328% 11/13/2024 Great Point Partners LLC2,790,698$3.49M1.0%N/A9.337% 2/7/2024 Ieq Capital LLC30,799$35K0.0%-21.4%0.163% 11/15/2023 Affinity Asset Advisors LLC265,958$527K0.1%N/A3.100% 11/15/2022 Northeast Financial Consultants Inc100,000$613K0.0%N/A1.166% 11/4/2022 Ieq Capital LLC39,191$240K0.0%N/A0.457% (Data available from 1/1/2016 forward) PMN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PMN shares? During the previous two years, the following institutional investors and hedge funds held shares of ProMIS Neurosciences shares: Great Point Partners LLC ($3.49M), Sphera Funds Management LTD. ($2.41M), Armistice Capital LLC ($1.62M), Ally Bridge Group NY LLC ($1.03M), Affinity Asset Advisors LLC ($527K), Allostery Investments LP ($165K), and Heights Capital Management Inc. ($152K).Learn more on PMN's institutional investors. What percentage of ProMIS Neurosciences stock is owned by institutional investors? 50.13% of ProMIS Neurosciences stock is owned by institutional investors. Learn more on PMN's institutional investor holdings. Which institutional investors have been buying ProMIS Neurosciences stock? The following institutional investors have purchased ProMIS Neurosciences stock in the last 24 months: Great Point Partners LLC ($2.79M), Ally Bridge Group NY LLC ($533.02K), Affinity Asset Advisors LLC ($265.96K), Allostery Investments LP ($233.70K), and Sphera Funds Management LTD. ($115.08K). How much institutional buying is happening at ProMIS Neurosciences? Institutional investors have bought a total of 3,938,466 shares in the last 24 months. This purchase volume represents approximately $5.04M in transactions. Which ProMIS Neurosciences major shareholders have been selling company stock? The following institutional investors have sold ProMIS Neurosciences stock in the last 24 months: Heights Capital Management Inc. ($226.69K), Armistice Capital LLC ($175.15K), Ally Bridge Group NY LLC ($107.91K), and Ieq Capital LLC ($8.39K). How much institutional selling is happening at ProMIS Neurosciences? Institutional investors have sold a total of 518,136 shares in the last 24 months. This volume of shares sold represents approximately $421.37K in transactions. Related Companies Renovaro Major Shareholders Klotho Neurosciences Major Shareholders Unicycive Therapeutics Major Shareholders Repare Therapeutics Major Shareholders Assertio Major Shareholders NRx Pharmaceuticals Major Shareholders Clearside Biomedical Major Shareholders Exicure Major Shareholders PMV Pharmaceuticals Major Shareholders Outlook Therapeutics Major Shareholders This page (NASDAQ:PMN) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProMIS Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProMIS Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PMN Stock Free PMN Stock Alerts